Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALOGLIPTIN vs ALPRAZOLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALOGLIPTIN vs ALPRAZOLAM: Safety Overview

Metric ALOGLIPTIN ALPRAZOLAM
Total FAERS Reports 1,385 48,357
Deaths Reported 122 16,072
Death Rate 8.8% 33.2%
Hospitalizations 567 15,996
Average Patient Age 69.0 yrs 48.1 yrs
% Female Patients 41.0% 60.4%
FDA Approval Date Jan 25, 2013 Approved Prior to Jan 1, 1982
Manufacturer Padagis Israel Pharmaceuticals Ltd Endo USA, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription